Comments on: Coherus Presents Preliminary Results from Phase I Dose Escalation Study of its Anti-chemokine receptor 8 (CCR8) Antibody, CHS-114, at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting https://insideout.vn/coherus-presents-preliminary-results-from-phase-i-dose-escalation-study-of-its-anti-chemokine-receptor-8-ccr8-antibody-chs-114-at-the-2024-american-society-of-clinical-oncology-asco-annual-meet/ Inside Out Thu, 23 May 2024 21:51:00 +0000 hourly 1 https://wordpress.org/?v=6.6.2